ICUCW — SeaStar Medical Holding Corp

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1831868 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 495,000 449,000 -3,603,000 -3,521,000 11,263,000 9,348,000 3,948,000
Dec 2025 420,000 408,000 -3,016,000 -2,904,000 14,158,000 11,980,000 3,742,000
Sep 2025 183,000 169,000 -3,579,000 -3,472,000 15,530,000 13,763,000 4,066,000
Jun 2025 338,000 311,000 -1,756,000 -2,002,000 8,383,000 6,302,000 5,042,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-13,599,000
Investing CF
Financing CF
$23,760,000
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-151,714,000
Inventory
$66,000
Receivables
$237,000
ST Investments
EBIT TTM
$-12,114,000
Pretax Income TTM
$-12,147,000
Interest Exp TTM
$33,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,436,000
EBITDA
Free Cash Flow
$-9,533,750
Enterprise Value
Total Cash
$9,348,000
Total Debt
$331,000
Shares Out
Trailing EPS
Book Value
$2.71
ROE
-302.0%
ROA
-79.2%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,234,000 -12,175,000 -12,150,000 14,158,000 3,742,000 -13,599,000
Dec 2024 135,000 -17,842,000 -24,830,000 4,658,000 6,841,000 -16,007,000
Dec 2023 0 -14,210,000 -26,232,000 3,513,000 17,383,000 -10,285,000
Dec 2022 0 -11,609,000 -12,190,000 3,038,000 23,800,000 -7,794,000

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-12,697,000
OpCashFlow TTM
$0
Assets (Latest)
$4,658,000
Forward EPS

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $154.64B $436.64
SYK STRYKER CORP $119.99B $313.00
MDT Medtronic plc $99.63B $77.60
BSX BOSTON SCIENTIFIC CORP $85.67B $57.64
MMM 3M CO $80.34B $154.03

News headlines (Yahoo Finance, 1h cache)

ICU: YoY Revenue Increases 69%
2026-05-18 11:15 · Yahoo
SeaStar Medical Holding Corporation Q2 2026 Earnings Call Summary
2026-05-14 12:30 · Yahoo
SeaStar Medical Holding Corp (ICU) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
2026-05-14 05:01 · Yahoo
SeaStar Medical (ICU) Q1 2026 Earnings Transcript
2026-05-13 21:48 · Yahoo
Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call
2026-05-13 21:20 · Yahoo
SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
2026-05-13 20:05 · Yahoo
SeaStar Medical to Report First Quarter Financial Results on May 13, 2026
2026-05-06 12:20 · Yahoo
ICU: Poster Presentations at AKI & CRRT 2026 Highlight SAVE Registry Data and SCD MOA
2026-04-01 10:35 · Yahoo
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
2026-03-30 12:20 · Yahoo
SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
2026-03-26 03:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.